Arkolith/Insider Trading/AVTE/Form 4

Verwijs Marinus

CHIEF TECHNICAL OFFICERAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed Apr 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$155K
Net Open-Market Flow
-$155K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Sell(S)4K$28.87$110K2K
Apr 1, 2024Sell(S)2K$30.00$45K0
Apr 1, 2024Option exercise(M)5K$14.59$77K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2024Option exercise(M)5K—$079K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-010139) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML